Evidence map›Paper›PMID 42797384›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Paeoniflorin Alleviates Oxygen-Glucose Deprivation/Reoxygenation Injury by Mediating Crosstalk Between Neurons and Endothelial Cells Through the VEGF/PI3K-AKT/mTOR Pathway.

Zike Xu, Hongxia Luo, Yimin Zhao, Xuhui Wang, Sha Chen

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zike XuKey Laboratory of Biochemistry and Molecular Pharmacology, Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.
Hongxia LuoKey Laboratory of Biochemistry and Molecular Pharmacology, Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.
Yimin ZhaoKey Laboratory of Biochemistry and Molecular Pharmacology, Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.
Xuhui WangDepartment of Neurosurgery, The Second Afffliated Hospital of Chongqing Medical University, 76 Linjiang Road, Chongqing 400010, China.
Sha ChenKey Laboratory of Biochemistry and Molecular Pharmacology, Department of Pharmacology, Chongqing Medical University, Chongqing 400016, China.

Funding

China Postdoctoral Science Foundation 2022MD713710Chongqing Municipal Bureau of Human Resources and Social Security 2021XM3063Chongqing Municipality Education Commission KJQN202200458Chongqing Municipal Training Program of Innovation and Entrepreneurship for Undergraduates s202410631056Chongqing Science and Technology Commission CSTB2022NSCQ-MSX1097
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cerebral ischemia–reperfusion injurycrosstalknetwork pharmacologyneuroprotectionpaeoniflorinVEGF/PI3K-AKT/mTOR pathway

Identifiers

PMID42797384
PMCPMC13610193

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.